BCL6B and hepatocellular carcinoma: Taken together, the data presented here showed that the loss of BCL6B expression was significantly correlated with HCC progression and was an independent prognostic marker of poor overall survival in HCC patients, as well as added significant prognostic value to well-known clinical prognostic factors.